2Xideas AG Has $13.72 Million Position in Ryan Specialty Holdings Inc. $RYAN

2Xideas AG boosted its position in Ryan Specialty Holdings Inc. (NYSE:RYAN) by 11.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 201,819 shares of the company’s stock after buying an additional 21,161 shares during the quarter. Ryan Specialty makes up approximately 2.4% of 2Xideas AG’s portfolio, making the stock its 8th biggest position. 2Xideas AG’s holdings in Ryan Specialty were worth $13,722,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Bank of Nova Scotia boosted its stake in shares of Ryan Specialty by 23.3% in the 2nd quarter. Bank of Nova Scotia now owns 5,528 shares of the company’s stock valued at $376,000 after purchasing an additional 1,045 shares in the last quarter. Cerity Partners LLC lifted its stake in Ryan Specialty by 13.1% in the second quarter. Cerity Partners LLC now owns 7,778 shares of the company’s stock worth $529,000 after purchasing an additional 898 shares during the last quarter. Federated Hermes Inc. boosted its position in Ryan Specialty by 36.9% during the second quarter. Federated Hermes Inc. now owns 733,446 shares of the company’s stock valued at $49,867,000 after buying an additional 197,594 shares during the period. Cresset Asset Management LLC grew its stake in shares of Ryan Specialty by 2.9% during the second quarter. Cresset Asset Management LLC now owns 28,705 shares of the company’s stock valued at $1,952,000 after buying an additional 814 shares during the last quarter. Finally, Marshall Wace LLP increased its holdings in shares of Ryan Specialty by 142.1% in the second quarter. Marshall Wace LLP now owns 380,116 shares of the company’s stock worth $25,844,000 after buying an additional 223,124 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Price Performance

Shares of RYAN stock opened at $53.86 on Tuesday. The company has a debt-to-equity ratio of 2.72, a quick ratio of 1.00 and a current ratio of 1.00. Ryan Specialty Holdings Inc. has a fifty-two week low of $50.08 and a fifty-two week high of $77.16. The firm has a market cap of $14.21 billion, a P/E ratio of 117.08, a P/E/G ratio of 1.54 and a beta of 0.61. The business’s 50 day moving average price is $55.63 and its 200-day moving average price is $59.70.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, October 30th. The company reported $0.47 EPS for the quarter, meeting analysts’ consensus estimates of $0.47. The company had revenue of $754.58 million during the quarter, compared to the consensus estimate of $742.35 million. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.The firm’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.41 earnings per share. On average, equities research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 25th. Stockholders of record on Tuesday, November 11th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, November 10th. Ryan Specialty’s dividend payout ratio (DPR) is currently 104.35%.

Insider Buying and Selling at Ryan Specialty

In related news, Chairman Patrick G. Ryan bought 276,634 shares of the business’s stock in a transaction dated Friday, September 12th. The shares were purchased at an average price of $51.84 per share, with a total value of $14,340,706.56. Following the purchase, the chairman owned 13,699,959 shares of the company’s stock, valued at approximately $710,205,874.56. This trade represents a 2.06% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 52.21% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on RYAN. TD Cowen dropped their target price on Ryan Specialty from $89.00 to $76.00 and set a “buy” rating for the company in a report on Wednesday, November 26th. Jefferies Financial Group initiated coverage on Ryan Specialty in a research report on Monday, December 1st. They issued a “hold” rating and a $64.00 price objective for the company. Citigroup initiated coverage on shares of Ryan Specialty in a report on Wednesday, August 13th. They issued a “buy” rating and a $74.00 target price on the stock. Morgan Stanley lifted their target price on shares of Ryan Specialty from $65.00 to $67.00 and gave the stock an “overweight” rating in a research note on Monday, November 17th. Finally, Wolfe Research raised shares of Ryan Specialty to a “strong-buy” rating in a research report on Tuesday, September 16th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Ryan Specialty has an average rating of “Moderate Buy” and an average price target of $66.60.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.